Research & Development
TherapeuticsMD Announces the FDA has Granted Annovera Marketing Exclusivity as a New Chemical Entity
21 September 2018 - - US-based women's healthcare company TherapeuticsMD, Inc.'s (NASDAQ: TXMD) Annovera (segesterone acetate and ethinyl estradiol vaginal system) has been gr...
Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
21 September 2018 - - US-based biopharmaceutical company Pfizer Inc.'s (NYSE: PFE) 20-Valent Pneumococcal Conjugate Vaccine (20vPnC) candidate, PF-06482077, received Breakthrough Therapy designat...
Circulogene Expands Testing Menu with Somatic BRCA1/2 Blood Testing
21 September 2018 - - US-based molecular genetics testing company Circulogene has expanded its testing menu to include somatic BRCA1/2 blood testing, the company said.

According to the co...
Celltrion Signs 'Incubation' Agreement with Emory University for Development of New Drugs for Atherosclerosis
21 September 2018 - - South Korea-based biopharmaceutical company Celltrion, Inc. (KRX: 068270) has signed an 'Incubation' agreement with Emory University in Atlanta to support the rese...
Synedgen Names Parker as Chief Business Officer
21 September 2018 - - US-based glycopolymer-based therapeutics developer Synedgen has appointed Kaveri Parker, Ph.D. as chief business officer, the company said.

In her role, she will lea...
Sunovion Wins Health Canada Approval of Aptiom as Adjunctive Therapy for the Treatment of Partial-Onset Seizures in Adolescents and Children above Six Years of Age
21 September 2018 - - Health Canada approved a Supplemental New Drug Submission to expand the indication for US-based Sunovion Pharmaceuticals Inc's antiepileptic drug Aptiom (eslicarbazepine ace...
Related Headlines

Medtronic to acquire Mazor Robotics to transform spinal procedures and improve outcomes through fully-integrated surgical solutions

Vanda announces addition of the HETLIOZ patent in the US FDA's orange book

Leica Microsystems wins US FDA's 510(k) clearance for augmented reality GLOW800 vascular fluorescence for vascular neurosurgery

European Medicines Agency Validates Bristol-Myers Squibb's Application for Empliciti Plus Pomalidomide and Low-Dose Dexamethasone in Patients with Multiple Myeloma

AmpliPhi Biosciences Receives Positive FDA Feedback for its Clinical Stage Bacteriophage Product Candidate AB-PA01 Targeting Pseudomonas Aeruginosa Infections

Rapamycin Holdings Opens First Human Clinical Trial of its eRapa Compound Targeting Early Stage Prostate Cancer

Blum Named Chairman of Gamida Cell's Board of Directors

Propanc Biopharma signs research agreement for the POP1 drug discovery programme with the University of Jaén, Spain

Leiters to ship new repackaged Avastin under US FDA 2018 guidance

OBI Pharma Inc wins US FDA's orphan drug designation for OBI-3424 for Acute Lymphoblastic Leukemia

DFB Soria Completes a Phase 2 Clinical Trial of Submicron Particle Paclitaxel Anhydrous Ointment for Actinic Keratosis

Agendia and Genecast Biotechnology Partner to Launch MammaPrint and BluePrint in China

Relmada Therapeutics Updates on Phase 2 Study of REL-1017 in Patients with Major Depressive Disorder

Braeburn Touts Positive Top-line Phase 3 Results for CAM2038 in Chronic Low Back Pain Patients Previously on Long-term Daily Opioid Therapy

Micreos passes US FDA approval for PhageGuard-E to combat E. Coli O157